Liposic (Carbomer)

Carbomer is a high‑molecular‑weight acrylic acid polymer that swells in aqueous media to form a gel matrix. In ophthalmic solutions it creates a viscous, muco‑adhesive layer that stabilises the tear film, enhances drug retention, and reduces evaporation, thereby improving comfort and therapeutic efficacy.

The dosage of Liposic is determined by the prescribing ophthalmologist or pharmacist based on the specific formulation and patient needs. Typical administration involves instilling one to two drops into the affected eye(s) as directed, with frequency ranging from several times daily to as needed.

Carbomer is classified as an inert excipient with limited systemic absorption. While no specific contraindications have been reported, use during pregnancy or lactation should only be undertaken if the potential benefit outweighs any theoretical risk, and under the guidance of a qualified healthcare professional.

To place an order, submit an enquiry on the Liposic product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with other ophthalmic viscosity agents such as hyaluronic acid or hydroxypropyl methylcellulose, carbomer offers a high degree of thickening at low concentrations and forms clear, non‑cloudy gels. It provides rapid viscosity build‑up and good stability, though some patients may experience transient stinging, whereas hyaluronic acid may be better tolerated but is more costly.

Liposic should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations. Do not freeze. Before use, inspect the container for any signs of contamination or degradation and discard if the appearance changes.

Liposic is supplied as an ophthalmic gel or solution intended for topical ocular use. The patient should wash hands, tilt the head back, and instill the prescribed number of drops into the conjunctival sac of each eye, avoiding contact between the dropper tip and the eye or surrounding tissues. The medication may be used with or without contact lenses, depending on the clinician’s advice.

Although carbomer is generally well tolerated, rare but serious adverse events can include severe allergic reactions such as ocular edema, conjunctival hyperemia, or corneal ulceration. Patients should discontinue use and seek immediate medical attention if they experience intense pain, vision changes, swelling, or persistent redness, as these may indicate a hypersensitivity or complication requiring prompt evaluation.

Liposic should be avoided in individuals with a known hypersensitivity to carbomer or any component of the formulation. It is also contraindicated in patients who have experienced severe ocular inflammation or infection that could be aggravated by a viscous agent, and in those where the prescribing clinician determines that alternative therapy is more appropriate.